ACC 2013.

The most relevant articles and presentations, daily report from the ACC 2013 congress, held in San Francisco, 9 – 11 march

Como cada año se realizó la Convocation Ceremony en la que tuvo lugar el recambio de autoridades del American College of Cardiology. El presidente saliente Dr. William Zoghbi, dio lugar a la asunción del nuevo presidente, Dr. John Gordon Harold, quien ofreció su mensaje de bienvenida. Participaron autoridades de las sociedades de cardiología de todo el mundo y en representación de SOLACI nuestro presidente el Dr. Oscar Mendiz. También se tomó juramento a nuevos Fellows del ACC entre los cuales se encontraban destacados miembros de SOLACI.

If you cannot view the articles, click here

More articles by this author

EuroPCR 2024

Here are the most important scientific articles of the EuroPCR 2024 Scientific Sessions. If you cannot view the articles, click here

ACC 2024

Here are the most important scientific articles of the ACC 2024 Scientific Sessions. If you cannot view the articles, click here

AHA 2023

Here are the most important scientific articles of the AHA 2023 Congress. If you cannot view the articles, click here

TCT 2023

Here are the most important scientific articles of the TCT 2023 Congress. If you cannot view the articles, click here

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

T-TEER: Beyond Traditional Pulmonary Hypertension Thresholds

Significant tricuspid regurgitation (TR) is associated with progressive functional deterioration, heart failure (HF) hospitalizations, and increased mortality. In recent years, transcatheter tricuspid edge-to-edge repair...

Is left atrial appendage closure safe in patients with reduced ejection fraction?

Patients with heart failure with reduced ejection fraction (HFrEF) were excluded from the major randomized trials evaluating percutaneous left atrial appendage closure (LAAC), and...

Left Atrial Appendage Closure in Spain: Sustained Growth and Favorable Real-World Outcomes

Oral anticoagulation remains the standard treatment for stroke prevention in patients with atrial fibrillation. However, many patients have a high bleeding risk or contraindications...